Review



incubation by elisa  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    R&D Systems incubation by elisa
    Incubation By Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1116 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/incubation+with+vegf/Human+VEGF+Quantikine+ELISA+Kit/us11771767-648-17-20
    Average 97 stars, based on 1116 article reviews
    incubation by elisa - by Bioz Stars, 2026-09
    97/100 stars

    Images



    Similar Products

    96
    Santa Cruz Biotechnology incubation with vegf
    Incubation With Vegf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/incubation+with+vegf/VEGF+Antibody/pm40499218-118-13-17
    Average 96 stars, based on 1 article reviews
    incubation with vegf - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    97
    R&D Systems incubation by elisa
    Incubation By Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/incubation+with+vegf/Human+VEGF+Quantikine+ELISA+Kit/us11771767-648-17-20
    Average 97 stars, based on 1 article reviews
    incubation by elisa - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    96
    R&D Systems incubation with vegf
    Incubation With Vegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/incubation+with+vegf/Recombinant+Human+VEGF+165+Protein/us11673945-484-36-40
    Average 96 stars, based on 1 article reviews
    incubation with vegf - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    ATCC post incubation huvecs human umbilical vein endothelial cells isvs intersegmental vessels l striatum ligusticum striatum dc mtt 3
    Post Incubation Huvecs Human Umbilical Vein Endothelial Cells Isvs Intersegmental Vessels L Striatum Ligusticum Striatum Dc Mtt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/incubation+with+vegf/Endothelial+Cell+Growth+Kit-VEGF/pm34597652-70-53-141
    Average 96 stars, based on 1 article reviews
    post incubation huvecs human umbilical vein endothelial cells isvs intersegmental vessels l striatum ligusticum striatum dc mtt 3 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Proteintech incubation with vegf
    a Prediction of putative-binding sites between miR-578 and <t>VEGF</t> by miRDB. b Negative correlation between miR-578 expression and VEGF. c Luciferase reporter assay indicated that VEGF DEL abrogated the inhibition of VEGF promoter activity. ** P < 0.01, vs control. d–g VEGF expression in cells expressing control, miR-578 or miR-578 inhibitor was detected by western blot and real-time PCR, respectively. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control. miR-578 in, miR-578 inhibitor.
    Incubation With Vegf, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/incubation+with+vegf/VEGF+Antibody/pmc06944700-72-13-29
    Average 96 stars, based on 1 article reviews
    incubation with vegf - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology primary antibody incubation
    a Prediction of putative-binding sites between miR-578 and <t>VEGF</t> by miRDB. b Negative correlation between miR-578 expression and VEGF. c Luciferase reporter assay indicated that VEGF DEL abrogated the inhibition of VEGF promoter activity. ** P < 0.01, vs control. d–g VEGF expression in cells expressing control, miR-578 or miR-578 inhibitor was detected by western blot and real-time PCR, respectively. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control. miR-578 in, miR-578 inhibitor.
    Primary Antibody Incubation, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/incubation+with+vegf/VEGF-C+Antibody/pm28344213-68-9-18
    Average 94 stars, based on 1 article reviews
    primary antibody incubation - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    a Prediction of putative-binding sites between miR-578 and VEGF by miRDB. b Negative correlation between miR-578 expression and VEGF. c Luciferase reporter assay indicated that VEGF DEL abrogated the inhibition of VEGF promoter activity. ** P < 0.01, vs control. d–g VEGF expression in cells expressing control, miR-578 or miR-578 inhibitor was detected by western blot and real-time PCR, respectively. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control. miR-578 in, miR-578 inhibitor.

    Journal: Cell Death & Disease

    Article Title: Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression

    doi: 10.1038/s41419-019-2204-y

    Figure Lengend Snippet: a Prediction of putative-binding sites between miR-578 and VEGF by miRDB. b Negative correlation between miR-578 expression and VEGF. c Luciferase reporter assay indicated that VEGF DEL abrogated the inhibition of VEGF promoter activity. ** P < 0.01, vs control. d–g VEGF expression in cells expressing control, miR-578 or miR-578 inhibitor was detected by western blot and real-time PCR, respectively. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control. miR-578 in, miR-578 inhibitor.

    Article Snippet: Then membranes were blocked with 5% blocking solution for 1 h, followed by incubation with VEGF (19003-1-AP), cyclin-dependent kinase 4 (CDK4) (11026-1-AP), and matrix metallopeptidase 9 (MMP9) (10375-2-AP) antibodies (Proteintech Group, Inc, Rosemont, IL, USA) overnight at 4 °C.

    Techniques: Binding Assay, Expressing, Luciferase, Reporter Assay, Inhibition, Activity Assay, Control, Western Blot, Real-time Polymerase Chain Reaction

    a Proliferation in cells expressing control, circ_001621 or combination was detected by the MTT assay. b Migration of MG63 cells expressing control, circ_001621 or combination was detected by the transwell assay. The indicated genes expression in MG63 cells were detected by western blot ( c ) and real-time PCR ( d ), separately. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control, ## P < 0.01, vs circ_001621. e Immunofluorescent stain of VEGF in the indicated MG63 cells. Green, VEGF; Blue, DAPI.

    Journal: Cell Death & Disease

    Article Title: Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression

    doi: 10.1038/s41419-019-2204-y

    Figure Lengend Snippet: a Proliferation in cells expressing control, circ_001621 or combination was detected by the MTT assay. b Migration of MG63 cells expressing control, circ_001621 or combination was detected by the transwell assay. The indicated genes expression in MG63 cells were detected by western blot ( c ) and real-time PCR ( d ), separately. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control, ## P < 0.01, vs circ_001621. e Immunofluorescent stain of VEGF in the indicated MG63 cells. Green, VEGF; Blue, DAPI.

    Article Snippet: Then membranes were blocked with 5% blocking solution for 1 h, followed by incubation with VEGF (19003-1-AP), cyclin-dependent kinase 4 (CDK4) (11026-1-AP), and matrix metallopeptidase 9 (MMP9) (10375-2-AP) antibodies (Proteintech Group, Inc, Rosemont, IL, USA) overnight at 4 °C.

    Techniques: Expressing, Control, MTT Assay, Migration, Transwell Assay, Western Blot, Real-time Polymerase Chain Reaction, Staining

    The lung ( a ) and liver metastatic foci ( b ) were validated by hematoxylin and eosin staining. The number of metastatic foci in each mouse was shown in the right panel. con control, circ circ_001621, miR miR-578. ** P < 0.01, vs control; ## P < 0.01, vs circ_001621. c Immunohistochemistry of VEGF expression in lung metastasis. The indicated genes expression was measured using western blot ( d ) and real-time PCR ( e ), respectively. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control; ns, P > 0.05, vs circ_001621; ## P < 0.01, vs circ_001621.

    Journal: Cell Death & Disease

    Article Title: Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression

    doi: 10.1038/s41419-019-2204-y

    Figure Lengend Snippet: The lung ( a ) and liver metastatic foci ( b ) were validated by hematoxylin and eosin staining. The number of metastatic foci in each mouse was shown in the right panel. con control, circ circ_001621, miR miR-578. ** P < 0.01, vs control; ## P < 0.01, vs circ_001621. c Immunohistochemistry of VEGF expression in lung metastasis. The indicated genes expression was measured using western blot ( d ) and real-time PCR ( e ), respectively. Results represented the mean ± s.d. of three independent experiments. ** P < 0.01, vs control; ns, P > 0.05, vs circ_001621; ## P < 0.01, vs circ_001621.

    Article Snippet: Then membranes were blocked with 5% blocking solution for 1 h, followed by incubation with VEGF (19003-1-AP), cyclin-dependent kinase 4 (CDK4) (11026-1-AP), and matrix metallopeptidase 9 (MMP9) (10375-2-AP) antibodies (Proteintech Group, Inc, Rosemont, IL, USA) overnight at 4 °C.

    Techniques: Staining, Control, Immunohistochemistry, Expressing, Western Blot, Real-time Polymerase Chain Reaction